Nunzia Pharmaceutical
$0.000100
3
+$0.00+0%Thursday 20:00
Statistics
Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
10,000
Avg. Volume
0
Mkt Cap
43,451.5
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Sep 30Expected
Q1 2018
Q2 2018
-0.13
-0.12
-0.1
-0.09
Expected EPS
N/A
Actual EPS
-0.1338
Financials
-Profit Margin
Unprofitable0Revenue
-78.06MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Show More
CEO
Sara Gonzales
Employees
4
Country
United States
ISIN
US67097W1027
Listings
0 Comments
Share your thoughts
FAQs
What is Nunzia Pharmaceutical stock price today?▼
The current price of NUNZ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Nunzia Pharmaceutical stock price performance more closely on the chart.
What is Nunzia Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nunzia Pharmaceutical stocks are traded under the ticker NUNZ.
Is Nunzia Pharmaceutical stock price growing?▼
NUNZ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nunzia Pharmaceutical has showed a +0% increase.
What is Nunzia Pharmaceutical market cap?▼
Today Nunzia Pharmaceutical has the market capitalization of 43,451.5
What were Nunzia Pharmaceutical earnings last quarter?▼
NUNZ earnings for the last quarter are -0.13 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nunzia Pharmaceutical revenue for the last year?▼
Nunzia Pharmaceutical revenue for the last year amounts to 0 USD.
What is Nunzia Pharmaceutical net income for the last year?▼
NUNZ net income for the last year is -78.06M USD.
How many employees does Nunzia Pharmaceutical have?▼
As of November 2, 2026, the company has 4 employees.
In which sector is Nunzia Pharmaceutical located?▼
Nunzia Pharmaceutical operates in the Health & Wellness sector.
When did Nunzia Pharmaceutical complete a stock split?▼
The last stock split for Nunzia Pharmaceutical was on December 4, 2019 with a ratio of 1:7000.
Where is Nunzia Pharmaceutical headquartered?▼
Nunzia Pharmaceutical is headquartered in Long Beach, United States.